You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
27 November 2025 - Chinese biopharmaceutical company Gan & Lee Pharmaceuticals Co., Ltd. (SHA: 603087) announced on Thursday that it has begun GRADUAL-3, its third large-scale phase 3 study of the GLP-1 receptor agonist bofanglutide (GZR18) in ov...
27 November 2025 - Swedish biopharmaceutical company Mendus AB (STO:IMMU) on Thursday reported positive two-year follow-up data from the ALISON Phase 1 trial, confirming the safety, tolerability and feasibility of vididencel as an active immunotherap...
27 November 2025 - South Korean biotech company SK Biopharmaceuticals Co Ltd announced on Wednesday that it has signed a licence agreement with the Wisconsin Alumni Research Foundation (WARF).Under this agreement SK Biopharmaceuticals will acquire th...
26 November 2025 - Healthcare solutions provider GE HealthCare (Nasdaq: GEHC) announced on Wednesday that it has received U.S. FDA Premarket Authorization for Pristina Recon DL, a 3D mammography reconstruction technology powered by deep learning. The...
26 November 2025 - Oncology company BeOne Medicines Ltd (Nasdaq: ONC) (HKEX: 06160) (SSE: 688235) announced on Wednesday that the U.S. Food and Drug Administration has granted Priority Review to the company's New Drug Application for sonrotoclax...
26 November 2025 - Remington Medical has confirmed that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its updated VascuChek® Doppler, marking the official commercial launch of the second-generation device. Designed ...
26 November 2025 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) on Wednesday reported positive final Phase 2 immunogenicity and safety results for its Lyme disease vaccine candidate, VLA15.The study showed strong anamnestic immune re...